Skip to main content
Figure 4 | Molecular Medicine

Figure 4

From: Delayed Administration of Pyroglutamate Helix B Surface Peptide (pHBSP), a Novel Nonerythropoietic Analog of Erythropoietin, Attenuates Acute Kidney Injury

Figure 4

Effect of pHBSP and EPO on NF-κB activation in the kidney after sham operation (Sham, n = 3) or renal ischemia-reperfusion injury (IRI, n = 3; IRI + pHBSP, n = 3 [10 ng/kg pHBSP administered 6 h into reperfusion]; and IRI + EPO, n = 3 [1,000 IU/kg EPO administered 4 h into reperfusion]). Data are expressed as means ± SEM for n number of observations. P < 0.05 versus IRI. O.D., optical density.

Back to article page

Molecular Medicine

ISSN: 1528-3658